{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:39Z","timestamp":1793643339857,"version":"4.5.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.mycmed.2022.101332","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T12:50:01Z","timestamp":1663159801000},"page":"101332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review"],"prefix":"10.1016","volume":"33","author":[{"given":"Durga Shankar","family":"Meena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal Krishana","family":"Bohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.mycmed.2022.101332_bib0001","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cmi.2020.12.035","article-title":"Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis","volume":"27","author":"Muthu","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101332_bib0003","first-page":"1629","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0004","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.idnow.2021.04.002","article-title":"Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: a systematic review of 235 cases","volume":"51","author":"Meena","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.mycmed.2022.101332_bib0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijantimicag.2017.08.010","article-title":"Antifungal resistance in mucorales","volume":"50","author":"Dannaoui","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2022.101332_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009711","article-title":"Azole-resistant Aspergillus fumigatus in the environment: identifying key reservoirs and hotspots of antifungal resistance","volume":"17","author":"Burks","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mycmed.2022.101332_bib0007","doi-asserted-by":"crossref","unstructured":"B Spellberg , Y Fu , JE Edwards Jr, AS Ibrahim Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 2005; 49:830\u20132. https:\/\/doi.org\/10.1128%2FAAC.49.2.830-832.2005","DOI":"10.1128\/AAC.49.2.830-832.2005"},{"key":"10.1016\/j.mycmed.2022.101332_bib0008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0009","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/myc.12222","volume":"57","author":"Abidi","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101332_bib0010","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101332_bib0011","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.mycmed.2022.101332_bib0012","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"French mycosis study group. Prospective pilot study of high-dose (10mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0013","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.mycmed.2022.101332_bib0014","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","article-title":"Mucormycosis in renal transplant recipients: review of 174 reported cases","volume":"17","author":"Song","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"VITAL and fungiscope mucormycosis investigators. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.mycmed.2022.101332_bib0016","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/myc.12428","article-title":"Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis","volume":"58","author":"Jeong","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101332_bib0017","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?","volume":"15","author":"Pongas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101332_bib0019","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.mycmed.2022.101332_bib0020","article-title":"Evolution of cross-resistance to medical triazoles in Aspergillus fumigatusthrough selection pressure of environmental fungicides","volume":"284","author":"Zhang","year":"2017","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.mycmed.2022.101332_bib0021","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/cid\/cir869","article-title":"Host defenses against zygomycetes","volume":"54","author":"Roilides","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000549","article-title":"Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mycmed.2022.101332_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00838-19","article-title":"Evaluation of the gradient concentration strip method for antifungal susceptibility testing of isavuconazole and comparators for mucoralesspecies","volume":"63","author":"Vidal","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0024","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/AAC.00004-15","article-title":"Etest cannot be recommended for in vitro susceptibility testing of mucorales","volume":"59","author":"Caramalho","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","article-title":"In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, sensititre yeastone, and the Etest","volume":"51","author":"Torres-Narbona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0026","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/jof7040271","article-title":"In Vitro antifungal drug resistance profiles of clinically relevant members of the mucorales (mucoromycota) especially with the newer triazoles","volume":"7","author":"Borman","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2022.101332_bib0027","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41429-021-00431-4","article-title":"Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY antifungal surveillance program (2011-2019)","volume":"74","author":"Pfaller","year":"2021","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.mycmed.2022.101332_bib0028","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/JCM.00318-16","article-title":"Role of antifungal susceptibility testing in non-aspergillus invasive mold infections","volume":"54","author":"Lamoth","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2022.101332_bib0029","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.01463-09","article-title":"Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice","volume":"54","author":"Rodr\u00edguez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179136","article-title":"Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates","volume":"12","author":"Guinea","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mycmed.2022.101332_bib0031","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2147\/IDR.S360191","article-title":"In vitro activity of isavuconazole and comparators against clinical isolates of molds from a multicenter study in China","volume":"15","author":"Jing","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.mycmed.2022.101332_bib0032","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2022.101332_bib0033","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/antibiotics9050227","article-title":"Review on current status of echinocandins use","volume":"9","author":"Mroczy\u0144ska","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.mycmed.2022.101332_bib0034","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/jof7100811","article-title":"Real-Life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation","volume":"7","author":"Glampedakis","year":"2021","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2022.101332_bib0036","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00628-08","article-title":"Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae","volume":"52","author":"Rodr\u00edguez","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0037","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/jac\/dkab233","article-title":"Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis","volume":"76","author":"Gebremariam","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0038","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101332_bib0039","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"MucoCovi network3. multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.mycmed.2022.101332_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101332_bib0041","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPH.0b013e3181ca0dcf","article-title":"Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma","volume":"32","author":"Roux","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.mycmed.2022.101332_bib0042","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"French Mycosis Study Group. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0043","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2021.03.005","article-title":"Antifungals in clinical use and the pipeline","volume":"35","author":"Johnson","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.mycmed.2022.101332_bib0044","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mycmed.2022.101332_bib0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The deferasirox-ambisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2022.101332_bib0046","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM and ISHAM. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2022.101332_bib0047","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin concentrations below the minimum inhibitory concentration attenuate the virulence of rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mycmed.2022.101332_bib0048","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.toxrep.2020.08.026","article-title":"Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: targeting ER-Chaperone GRP78 and Calpain-1 pathways","volume":"7","author":"Saleh","year":"2020","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.mycmed.2022.101332_bib0049","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"BV","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2022.101332_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/mmi.13071","article-title":"Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides","volume":"97","author":"Lee","year":"2015","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mycmed.2022.101332_bib0051","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12866-019-1475-x","article-title":"Antifungal and antibacterial effects of newly created lactic acid bacteria associations depending on cultivation media and duration of cultivation","volume":"19","author":"Matevosyan","year":"2019","journal-title":"BMC Microbiol"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:32Z","timestamp":1761110492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1156523322000890"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101332","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101332"}}